Virgo Surgical Video Solutions, Inc. Company Profile
Background
Overview
Virgo Surgical Video Solutions, Inc., established in 2017, is a technology company specializing in cloud-based solutions for endoscopic medicine. The company offers a comprehensive platform for video capture, management, and artificial intelligence (AI) analysis, aiming to enhance patient care through advanced video-based research and training initiatives. Virgo collaborates with a diverse range of healthcare providers, including academic institutions, integrated health systems, and private practices. The company's mission is to revolutionize endoscopic procedures by integrating cutting-edge technology to improve diagnostic accuracy and patient outcomes.
Mission and Vision
Virgo's mission is to advance endoscopic medicine by providing innovative, AI-driven solutions that streamline video capture and analysis, thereby improving clinical workflows and patient care. The company's vision is to become a global leader in endoscopic video solutions, empowering healthcare providers with tools that enhance diagnostic precision and operational efficiency.
Primary Area of Focus
Virgo focuses on developing and delivering cloud-based platforms that facilitate high-definition video capture, secure management, and AI-powered analysis of endoscopic procedures. The company's solutions are designed to integrate seamlessly with existing healthcare systems, supporting clinical research, training, and patient care.
Industry Significance
Operating within the medical equipment manufacturing industry, Virgo addresses the growing need for advanced technological solutions in endoscopy. By leveraging AI and cloud computing, Virgo contributes to the evolution of minimally invasive procedures, offering tools that enhance diagnostic capabilities and improve patient outcomes.
Key Strategic Focus
Core Objectives
- Innovation in Endoscopic Technology: Developing state-of-the-art platforms that integrate video capture with AI analysis to support clinical decision-making.
- Clinical Integration: Ensuring seamless compatibility with existing healthcare infrastructures to facilitate widespread adoption.
- Global Expansion: Extending the reach of Virgo's solutions to healthcare providers worldwide, enhancing the quality of endoscopic care globally.
Specific Areas of Specialization
- AI-Powered Video Analysis: Utilizing machine learning algorithms to analyze endoscopic videos, aiding in the detection and assessment of gastrointestinal conditions.
- Clinical Trial Support: Offering tools that assist in patient recruitment and data analysis for clinical studies, thereby accelerating research timelines.
Key Technologies Utilized
- Cloud Computing: Employing secure cloud infrastructure to store and manage large volumes of endoscopic video data.
- Artificial Intelligence: Implementing AI models, such as EndoDINO, to enhance the analysis and interpretation of endoscopic images.
- Data Integration: Ensuring compatibility with electronic health records (EHR) systems to streamline data flow and accessibility.
Primary Markets Targeted
- Healthcare Providers: Hospitals, clinics, and private practices seeking advanced tools for endoscopic procedures.
- Academic Institutions: Universities and research organizations conducting studies in gastroenterology and related fields.
- Pharmaceutical Companies: Organizations involved in clinical trials requiring efficient patient recruitment and data analysis tools.
Financials and Funding
Funding History
As of October 2025, Virgo has raised a total of $3.7 million in funding over six rounds. The latest funding round occurred on July 26, 2024, amounting to $3.7 million.
Notable Investors
Virgo's funding has been supported by various investors, including Waterline Ventures.
Utilization of Capital
The capital raised is intended to accelerate product development, expand market reach, and enhance Virgo's technological infrastructure to support the growing demand for advanced endoscopic solutions.
Pipeline Development
Key Pipeline Candidates
- EndoDINO: An AI foundation model for endoscopic imaging, trained on data from over 130,000 procedure videos, achieving state-of-the-art performance in various gastrointestinal endoscopy benchmarks.
- EndoML: A full-stack AI development platform that leverages EndoDINO, enabling organizations to build powerful AI models with less training data and securely extract AI features from their own endoscopy videos.
Stages of Development
- EndoDINO: Developed and trained, demonstrating high performance in gastrointestinal endoscopy tasks.
- EndoML: Launched in September 2025, offering a platform for healthcare providers and pharmaceutical companies to develop customized AI models.
Target Conditions
Both EndoDINO and EndoML are designed to enhance the detection and analysis of gastrointestinal conditions, including but not limited to:
- Colorectal Cancer: Improving early detection through enhanced imaging analysis.
- Inflammatory Bowel Disease: Aiding in the assessment and monitoring of disease progression.
- Gastric Ulcers: Facilitating accurate diagnosis and treatment planning.
Anticipated Milestones
- EndoDINO: Ongoing validation studies to further refine the model's accuracy and applicability across diverse patient populations.
- EndoML: Expansion of the platform's capabilities to support a broader range of endoscopic procedures and integration with additional healthcare systems.
Technological Platform and Innovation
Proprietary Technologies
- EndoDINO: A proprietary AI foundation model specifically developed for endoscopic imaging, utilizing self-supervised learning on large, unlabeled datasets.
- EndoML: A proprietary AI development platform that leverages EndoDINO to enable organizations to build customized AI models for endoscopic procedures.
Significant Scientific Methods
- Self-Supervised Learning: Utilizing Meta's DINOv2 architecture to facilitate self-supervised learning on large, unlabeled datasets, enhancing the model's ability to learn from vast amounts of endoscopic video data.
- Data Integration: Ensuring seamless integration with existing healthcare systems, including electronic health records (EHR), to facilitate efficient data flow and accessibility.
AI-Driven Capabilities
- Automated Image Analysis: Employing machine learning algorithms to analyze endoscopic images, aiding in the detection and assessment of gastrointestinal conditions.
- Predictive Modeling: Utilizing AI to predict disease progression and treatment outcomes, supporting personalized patient care.
Leadership Team
Key Executives
- Matt Schwartz: Co-founder and CEO. Matt has a background in healthcare technology and has been instrumental in developing Virgo's AI-driven solutions.
- C. L.: Vice President of Engineering. C. L. leads Virgo's engineering team, overseeing the development and implementation of the company's technological platforms.
- T. T.: Vice President of Operations. T. T. manages Virgo's operational strategies, ensuring efficient execution of the company's initiatives.
Leadership Changes
As of the latest available information, there have been no significant changes or appointments within Virgo's leadership team.
Competitor Profile
Market Insights and Dynamics
The market for endoscopic video solutions is experiencing growth, driven by the increasing adoption of minimally invasive procedures and the integration of AI in healthcare. Healthcare providers are seeking advanced tools to enhance diagnostic accuracy, improve patient outcomes, and streamline clinical workflows.
Competitor Analysis
Virgo operates in a competitive landscape with several key players:
- Humata Health: Provides prior authorization software for the healthcare industry.
- Qventus: Develops an AI-based care automation software platform.
- Thoughtful Automation: Offers an AI operating system for the healthcare industry.
- Artisight: Develops an AI chatbot for healthcare applications.
These competitors offer various AI-driven solutions targeting different aspects of healthcare, from administrative processes to patient engagement. Virgo differentiates itself by focusing specifically on endoscopic video capture and analysis, providing specialized tools tailored to the needs of gastroenterology and related fields.
Strategic Collaborations and Partnerships
Virgo has established collaborations with leading healthcare institutions, including The Cleveland Clinic, Mount Sinai, Mass General, and the University of Chicago. These partnerships enable Virgo to integrate its solutions into diverse clinical environments, gather extensive data for model training, and refine its technological offerings.